Ivabradine-d<sub>3</sub> (hydro<wbr/>chloride)

Ivabradine-d3 (hydrochloride)

CAT N°: 25711
Price:

From 322.00 273.70

Ivabradine-d3 is intended for use as an internal standard for the quantification of ivabradine (Item No. 15868) by GC- or LC-MS. Ivabradine is a hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blocker that blocks the mixed sodium/potassium inward funny current (If) in HEK293 cells expressing mouse HCN1, human HCN2, and human HCN4 (EC50s = 4.5, 4.52, and 4.28 ?M, respectively).{25789} In vivo, ivabradine (10 mg/kg per day) reduces heart rate, incidence of ventricular tachycardia and ventricular fibrillation, and arrhythmic mortality in a rat model of myocardial infarction.{37776} Formulations containing ivabradine have been used in the treatment of heart failure and angina.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (S)-3-(3-(((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl-d3)amino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one, monohydrochloride
  • Correlated keywords
    • 1217977-70-2 deuterated deuterium HEK-293 HCN-1 2 4 S 16257 S16257
  • Product Overview:
    Ivabradine-d3 is intended for use as an internal standard for the quantification of ivabradine (Item No. 15868) by GC- or LC-MS. Ivabradine is a hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blocker that blocks the mixed sodium/potassium inward funny current (If) in HEK293 cells expressing mouse HCN1, human HCN2, and human HCN4 (EC50s = 4.5, 4.52, and 4.28 ?M, respectively).{25789} In vivo, ivabradine (10 mg/kg per day) reduces heart rate, incidence of ventricular tachycardia and ventricular fibrillation, and arrhythmic mortality in a rat model of myocardial infarction.{37776} Formulations containing ivabradine have been used in the treatment of heart failure and angina.

We also advise you